多种生物标志物可预测冠状动脉慢性全闭症患者的主要心血管不良事件
Srikanth Adusumalli1, Cian P McCarthy1, Craig A Magaret2
1Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.
The American journal of cardiology
|January 8, 2025
概括
一个新的血液生物标志物小组有效预测冠状动脉慢性全闭症 (CTO) 患者的长期心血管风险,有助于更好的风险分层和患者护理.
科学领域:
- 心脏病学 心脏病学
- 生物标志物发现发现
- 预测 预测 预测 预测 预测
背景情况:
- 预测冠状动脉慢性完全闭塞 (CTO) 的长期预后仍然具有挑战性.
- 现有的CTO患者风险分层工具是有限的.
- 心血管 (CV) 事件对患有CTO的个人构成重大风险.
研究的目的:
- 评估之前描述的血液生物标志物小组,用于预测CTO患者的CV事件.
- 评估专家组区分重大心血管不良事件 (MACE) 和心血管死亡/心力衰竭 (HF) 住院治疗风险的能力.
- 确定这个生物标志物小组在CTO患者管理中的临床实用性.
主要方法:
- 分析了来自CASABLANCA研究中241名CTO患者的队列.
- 基线血液样本被用于评估一个由四个生物标志物组成的小组:损伤分子-1,N-终端亲B型尿素,骨质松素和金属蛋白酶-1的组织抑制剂-1.
- 患者平均被跟踪了4年,以记录MACE和CV死亡/HF住院事件.
主要成果:
- 生物标志物小组表现出强大的预测性能,MACE的C统计值为0.79,CV死亡/HF住院率为0.84.
- 与低风险组相比,由专家组分为中高风险的患者显示MACE (分别为6.65和12.4) 和心血管死亡/心血管疾病住院 (5.61和15.6) 的危险比率显著增加.
- 很大一部分患者经历了不良事件,其中27.8%患有MACE,23.2%在4年内经历心血管死亡/心血管疾病住院治疗.
结论:
- 一个多生物标志物小组有效地区分了冠状动脉CTO患者不良后果的风险.
- 这些发现支持使用该小组来改善CTO的风险分层和个性化患者护理.
- 生物标志物小组对于丰富CTO干预临床试验中的患者选择也可能是有价值的.
更多相关视频
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
3.4K
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
1.1K
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
96
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
96
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
56
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
56